U.S. flag

An official website of the United States government

NM_000372.5(TYR):c.1205G>A (p.Arg402Gln) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity; other (5 submissions)
Last evaluated:
Mar 1, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000085910.26

Allele description

NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)

Gene:
TYR:tyrosinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q14.3
Genomic location:
Preferred name:
NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)
Other names:
TYR, ARG402GLN (rs1126809)
HGVS:
  • NC_000011.10:g.89284793G>A
  • NG_008748.1:g.111922G>A
  • NM_000372.5:c.1205G>AMANE SELECT
  • NP_000363.1:p.Arg402Gln
  • NC_000011.9:g.89017961G>A
  • NM_000372.4:c.1205G>A
  • P14679:p.Arg402Gln
Protein change:
R402Q; ARG402GLN
Links:
UniProtKB: P14679#VAR_007686; OMIM: 606933.0009; dbSNP: rs1126809
NCBI 1000 Genomes Browser:
rs1126809
Molecular consequence:
  • NM_000372.5:c.1205G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
63

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000118053Retina International
no classification provided
not providednot providednot provided

SCV000340022Eurofins Ntd Llc (ga)
criteria provided, single submitter

(EGL Classification Definitions 2015)
Uncertain significance
(Oct 24, 2017)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link,

SCV000597779Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
other
(May 24, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001731474Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Feb 1, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002821657CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Pathogenic
(Mar 1, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown23not providednot providednot providednot providedclinical testing
not providedgermlineyes40not providednot providednot providednot providedclinical testing
not providednot providednot providednot providednot providednot provided1not providedliterature only
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutational mapping of the catalytic activities of human tyrosinase.

Tripathi RK, Hearing VJ, Urabe K, Aroca P, Spritz RA.

J Biol Chem. 1992 Nov 25;267(33):23707-12.

PubMed [citation]
PMID:
1429711

A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity.

Tripathi RK, Giebel LB, Strunk KM, Spritz RA.

Gene Expr. 1991 May;1(2):103-10.

PubMed [citation]
PMID:
1820207
PMCID:
PMC5952204
See all PubMed Citations (11)

Details of each submission

From Retina International, SCV000118053.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot providednot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1not providednot provided1not providednot providednot providednot providednot providednot provided

From Eurofins Ntd Llc (ga), SCV000340022.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided23not providednot providedclinical testing PubMed (9)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot provided23not providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV000597779.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

DNA sequence analysis of the TYR gene demonstrated a sequence change, c.1205G>A, in exon 4 that results in an amino acid change, p.Arg402Gln. The p.Arg402Gln substitution is a well-documented temperature-sensitive reduced function allele that alone is not sufficient to cause an oculocutaneous albinism phenotype. However, the p.Arg402Gln substitution, if found in compound heterozygous state with a pathogenic mutation, may be associated with a mild oculocutaneous albinism type 1B (OCA1B) or ocular albinism (OA) phenotype (PMIDs: 7704033, 19938076, 18463683, 18326704, 23504663). The p.Arg402Gln substitution has been described in the gnomAD database with a high population frequency of 28% in the European American population (dbSNP rs1126809). Some studies have suggested that the p.Arg402Gln substitution is not associated with mild OCA1B or OA phenotype, due to its high frequency in the general population and the presence of this variant in trans with a pathogenic variant in unaffected parents (PMID: 19208379). It has been proposed that the p.Arg402Gln variant causes a partial albinism phenotype only when paired with certain genetic backgrounds (PMIDs: 7704033, 19938076) and multiple studies have shown that the p.Arg402Gln variant is more common in OCA patients with one TYR pathogenic variant than in patients with two pathogenic variants (PMIDs: 18463683, 18326704, 19938076, 23504663).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001731474.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV002821657.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided40not providednot providedclinical testingnot provided

Description

TYR: PM3:Very Strong, PM2, PM5, PP4, BP4

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided40not providednot providednot provided

Last Updated: May 1, 2024